Body composition and risk factors associated with sarcopenia in post-COVID patients after moderate or severe COVID-19 infections

Table 2 Risk factors associated to sarcopenia in Post-COVID patients. Bivariate model

	OR	CI 95%	p-value
> 60 years old	3.98	2.46–6.45	< 0.001
Male	0.96	0.61–1.50	0.868
Diabetes	1.63	1.03–2.60	0.037
Hypertension	1.27	0.80–2.02	0.300
Obesity	2.17	1.06–4.43	0.033
Ischemic cardiopathy	1.03	0.43–2.42	0.945
Pulmonary disease	1.14	0.63–2.05	0.653
Thyroid disease	0.68	0.19–2.36	0.551
Hepatopathy	1.18	0.38–3.64	0.770
VIH	8.97	0.80–100.03	0.074
Asthma	0.39	0.05–3.09	0.376
COPD	3.63	0.95–13.79	0.058
Hospitalary parameters
IMV	2.14	1.29–3.52	0.003
Duration of IMV, d	1.05	1.01–1.09	0.003
Prolonged length of hospital stay, > 7 d	3.04	1.64–5.63	< 0.001
Arterial oxygen saturation, %	1.00	0.98–1.02	0.797
PaO₂, %	0.99	0.97–1.00	0.415
PaO₂/FiO₂ ratio	0.99	0.99–1.00	0.054
ARDS mild	1	Reference
ARDS moderade-severe	1.71	0.78–3.74	0.174

HIV, Human immunodeficiency virus; COPD, Chronic Obstructive Pulmonary Disease; IMV, Invasive Mechanical Ventilation; Pa0₂, Arterial partial pressure of oxygen; PaO2/FiO₂, Arterial partial pressure of oxygen/ Fraction of inspired oxygen; ARDS, Acute Respiratory Distress Syndrome

ISSN: 1471-2466